LTA antibody

Catalog No. ABIN2689811

Product Details anti-LTA Antibody

Target: LTA (Lymphotoxin-alpha (LTA))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This LTA antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Brand: BD Pharmingen™

Characteristics: The 359-238-8 antibody reacts with human lymphotoxin-α (LT-α, formerly known as TNF-β). The immunogen used to generate the 359-238-8 hybridoma was recombinant human LT-α. This is a neutralizing antibody. ELISA standard curve: Human LT-α

BD Pharmingen™ Purified Mouse Anti-Human LT-α - Purified - Clone 359-238-8 - Isotype Mouse IgG1 - Reactivity Hu - 1 mg

Purification: The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

Immunogen: Recombinant human LT-alpha

Clone: 359-238

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Concentration: 1.0 mg/mL

Buffer: Aqueous buffered solution containing ≤0.09 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store undiluted at 4°C.

References for anti-LTA antibody (ABIN2689811)

Meager, Parti, Leung, Woolley, Peil, Sidhu, Roberts: "A two-site sandwich immunoradiometric assay of human lymphotoxin with monoclonal antibodies and its applications." in: Journal of immunological methods, Vol. 104, Issue 1-2, pp. 31-42, (1988) (PubMed).

Target Details for LTA

Target: LTA (Lymphotoxin-alpha (LTA))

Alternative Name: LT-alpha (LTA Products)

Synonyms: LT antibody, TNFB antibody, TNFSF1 antibody, LT-[a] antibody, LT-alpha antibody, LT[a] antibody, LTalpha antibody, Ltx antibody, TNF-beta antibody, Tnfb antibody, Tnfsf1b antibody, hlb382 antibody, lymphotoxin alpha antibody, lymphotoxin A antibody, LTA antibody, Lta antibody

Target Type: Chemical

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process